Archive: 29/08/2012

Belimumab for lupus erythematosus: Added benefit not proven

Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...

Added benefit of fampridine is not proven

Fampridine (trade name Fampyra) has been approved in Germany since July 2011 for adult patients suffering from a higher grade walking disability (grades 4 to 7 on the EDSS disability status scale), as a result of multiple ...

Internet addiction—Causes at the molecular level

Everybody is talking about Internet addiction. Medically, this phenomenon has not yet been as clearly described as nicotine or alcohol dependency. But a study conducted by researchers from the University of Bonn and the Central ...

page 5 from 8